Bill To Ban Advertisement of Drugs Directly to the Public Introduced in Kentucky House

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Bill To Ban Advertisement of Drugs Directly to the Public Introduced in Kentucky House

J.W. Schomisch

February 9, 2024 at 09:32 AM EST

A bill that would ban all pharmaceutical ads to the general public was introduced in the Kentucky House of Representatives. House Bill 28 was referred to the House Committee on Committees. Violations would result in a fine not to exceed $100,000. “A fine shall be assessed for each purchase of an advertisement, not by the frequency of the advertisement in its published format... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Bill To Ban Advertisement of Drugs Directly to the Public Introduced in Kentucky House

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT